Literature DB >> 12680586

Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans.

Akinori Yoda1, Isao Oishi, Yasuhiro Minami.   

Abstract

Receptor tyrosine kinases (RTKs) play crucial roles in various developmental processes. Ror-family RTKs are characterized by the intracellular tyrosine kinase domains, highly related to those of the Trk-family RTKs, and by the extracellular Frizzled-like cysteine-rich domains (CRDs) and Kringle domains. Rors are evolutionally conserved among Caenorhabditis elegans, Aplysia, Drosophila melanogaster, Xenopus, mice, and humans. In D. melanogaster and mammals, pairs of structurally related Rors are found, while a single Ror protein is identified in C. elegans or Aplysia. In Aplysia and D. melanogaster, Rors are expressed exclusively in developing nervous systems. On the other hand, rather widespread expression of Rors was observed in C. elegans and mammals. Mutations in Ror of C. elegans cause inappropriate axon outgrowth as well as defects in cell migration and asymmetric cell division. It has also been reported that the nematode Ror possesses kinase-dependent and kinase-independent functions. Mouse Rors, Ror1, and Ror2, are expressed mainly in migrating neural crest cells and mesenchymal cells, and Ror2-deficient mice exhibit skeletal abnormalities and ventricular septal defects in the heart. Although Ror1-deficient mice exhibit no apparent skeletal or cardiac abnormalities, Ror1/Ror2 double mutant mice show markedly enhanced skeletal and cardiac abnormalities compared with Ror2 mutant mice, indicating genetic interaction of Ror1 and Ror2. In humans, mutations within Ror2 have been found in two genetic skeletal disorders, recessive Robinow syndrome and dominant Brachydactyly type B (BDB), further emphasizing critical functions of Ror2 during developmental morphogenesis. In this article, we also discuss the signaling machinery mediated by Ror-family RTKs with a particular emphasis on our recent structure-function analyses of Ror-family RTKs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680586     DOI: 10.1081/rrs-120018757

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  32 in total

Review 1.  Planar cell polarity signaling in craniofacial development.

Authors:  Jacek Topczewski; Rodney M Dale; Barbara E Sisson
Journal:  Organogenesis       Date:  2011-10-01       Impact factor: 2.500

2.  Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2.

Authors:  Sabrina Paganoni; Adriana Ferreira
Journal:  J Cell Sci       Date:  2005-01-15       Impact factor: 5.285

Review 3.  Wnt signaling through the Ror receptor in the nervous system.

Authors:  Iveta M Petrova; Martijn J Malessy; Joost Verhaagen; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

Review 4.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.

Authors:  Michael Y Choi; George F Widhopf; Emanuela M Ghia; Reilly L Kidwell; Md Kamrul Hasan; Jian Yu; Laura Z Rassenti; Liguang Chen; Yun Chen; Emily Pittman; Minya Pu; Karen Messer; Charles E Prussak; Januario E Castro; Catriona Jamieson; Thomas J Kipps
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

Review 6.  Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1.

Authors:  Michael Y Choi; George F Widhopf; Christina C N Wu; Bing Cui; Fitzgerald Lao; Anil Sadarangani; Joy Cavagnaro; Charles Prussak; Dennis A Carson; Catriona Jamieson; Thomas J Kipps
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06

7.  Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.

Authors:  Bing Cui; Suping Zhang; Liguang Chen; Jianqiang Yu; George F Widhopf; Jessie-F Fecteau; Laura Z Rassenti; Thomas J Kipps
Journal:  Cancer Res       Date:  2013-06-15       Impact factor: 12.701

8.  Novel Robinow syndrome causing mutations in the proximal region of the frizzled-like domain of ROR2 are retained in the endoplasmic reticulum.

Authors:  Bassam R Ali; Steve Jeffery; Neha Patel; Lorna E Tinworth; Nagwa Meguid; Michael A Patton; Ali R Afzal
Journal:  Hum Genet       Date:  2007-07-31       Impact factor: 4.132

9.  Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death.

Authors:  Iwona Ksiazek; Constanze Burkhardt; Shuo Lin; Riad Seddik; Marcin Maj; Gabriela Bezakova; Mathias Jucker; Silvia Arber; Pico Caroni; Joshua R Sanes; Bernhard Bettler; Markus A Ruegg
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

10.  Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma.

Authors:  T M Wright; A R Brannon; J D Gordan; A J Mikels; C Mitchell; S Chen; I Espinosa; M van de Rijn; R Pruthi; E Wallen; L Edwards; R Nusse; W K Rathmell
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.